Advertisement

PharmacoEconomics & Outcomes News

, Volume 838, Issue 1, pp 25–25 | Cite as

Prenatal screening for congenital toxoplasmosis worth extra cost

Clinical study
  • 13 Downloads

Reference

  1. Binquet C, et al. The cost-effectiveness of neonatal versus prenatal screening for congenital toxoplasmosis. PLOS One : 18 Sep 2019. Available from: URL: https://doi.org/10.1371/journal.pone.0221709

Copyright information

© Springer International Publishing AG 2019

Personalised recommendations